Doctor Daniel Gaudet
ECOGENE-21 and Community gene medicine center, clinical lipidology unit, Montreal (Canada)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Transition of patients with familial chylomicronaemia syndrome from volanesorsen to olezarsen: safety and pharmacokinetic results
Event: ESC Congress 2024
Topic: Drug therapy
Session: Secondary prevention: a multifactorial approach
Rationale and design of the SHASTA-3 and SHASTA-4 studies: randomized, double-blind, placebo-controlled, phase 3 studies of plozasiran in patients with severe hypertriglyceridemia
Event: ESC Congress 2024
Topic: Drug therapy
Session: Lipid-lowering therapies: new findings
ANGPTL3 antisense oligonucleotide to lower triglycerides
Event: ESC Congress 2020
Topic: Drug therapy
Session: Late-Breaking Science in Lipids
